NCT02278679

Brief Summary

A digital rectal exam proficiency tool, titled the 'DiRECT' was developed based on the consensus of 10 experts. The purpose of this study is to validate this tool for use in both undergraduate and graduate medical education .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
410

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

October 28, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 30, 2014

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

May 18, 2017

Status Verified

May 1, 2017

Enrollment Period

3.2 years

First QC Date

October 28, 2014

Last Update Submit

May 17, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Validate DiRECT tool

    2 years

Study Arms (3)

Anesthitized patient

First, it will be validated on 120 anesthetized patients undergoing prostate surgery comparing responses on the digital rectal exam clinical tool (DiRECT) from both expert and novice clinicians, with surgical pathology reports.

Procedure: Digital Rectal Exam

Standardized patients

During a standardized patient exercise focusing on digital rectal exam in the University of Virginia School of Medicine curriculum, 160 second-year medical students will be given the DiRECT to document their examination. An attending physician will also attend the standardized patient exercise and document their examination for comparison with the medical students.

Clinic patient

The third phase includes 8 residents and up to10 attendings in the Urology clinic, who will independently complete the DiRECT documenting their DRE in the course of usual care.

Interventions

The DRE digital rectal exam is an essential component of physical examination, but physicians enter their residency having neither been appropriately exposed nor trained in performing DREs. , the attending physician, resident physician(s), and medical student(s) will each perform a digital rectal exam on the subject, and independently document their examination on the DiRECT instrument.

Anesthitized patient

Eligibility Criteria

Age30 Years - 90 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects with Benign Prostate Hypertrophy, Prostate Cancer or routine digital exam being seen by Urology Attendings, residents or medical students.

You may qualify if:

  • Subjects who are patients:
  • Patients who are male and adults ≥ 30 years of age
  • Standardized patients between the ages of 30-80 years participating in the University of Virginia School of Medicine activity for second-year students learning digital rectal exams
  • Subjects who are clinicians:
  • Attending physician, resident physician, or medical student scrubbed in for a prostatectomy or cystectomy, seeing patients in urology clinic, or participating in the School of Medicine activity for second year students learning digital rectal exams

You may not qualify if:

  • Patients who do not have a prostate
  • Patients with previous pelvic/perineal surgery
  • Previously enrolled in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia Health System, Dept of Urology

Charlottesville, Virginia, 22908, United States

RECRUITING

MeSH Terms

Conditions

Prostatic HyperplasiaProstatic Neoplasms

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasms

Study Officials

  • Tracey L Krupski, M.D.

    University of Virginia, Dept of Urology

    PRINCIPAL INVESTIGATOR
  • Raymond A Costabile, M.D.

    University of Virginia, Dept of Urology

    STUDY CHAIR

Central Study Contacts

Tracey L Krupski, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Associate Professor of Urology

Study Record Dates

First Submitted

October 28, 2014

First Posted

October 30, 2014

Study Start

October 1, 2014

Primary Completion

December 1, 2017

Study Completion

June 1, 2018

Last Updated

May 18, 2017

Record last verified: 2017-05

Locations